Objectives: Pulmonary complications, such as atelectasis, pulmonary oedema, pleural effusion, bronchospasm, and pneumonia, have been reported following cardiac surgery. Shallow breathing leading to impaired lung function is the major cause of respiratory complications. Decreases in respiratory muscle strength can be measured using the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) produced in the oral cavity. This study aimed to determine the decrease in respiratory muscle strength 8 weeks following cardiac surgery. Moreover, the relationship between lung function and respiratory muscle strength was studied.
Conclusions: The respiratory muscle strength was not impeded either before or 2 months after cardiac surgery. However, the exact mechanism for the alteration in lung function remains unclear. Measures to re-establish the ideal postoperative lung capacity should concentrate on different perioperative pulmonary exercises.
Introduction
The complications of lung function impairment can be caused by various factors, one of which is pain. Owing to the presence of pain, shallow breathing may occur in patients, which will restrict their chest movement following cardiac surgery with median sternotomy.
1e7 The muscles for breathing, i.e. mainly the diaphragm, are important for inspiration. Surgeries in the chest might involve the muscles and nerves. Dysfunction of the respiratory muscles preoperatively might prolong mechanical ventilation after cardiac surgery, such as coronary artery bypass grafting (CABG), mitral valve replacement, and aortic valve replacement, and reduce respiratory muscle strength, which has been known to be a determinant of reduced functional capacity postoperatively. 8, 9 Decreases in respiratory muscle strength can be measured using the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) produced in the oral cavity; this has been reported in hospitalised patients after cardiac surgery.
10e13 Conversely, the reported recovery time after discharge ranged from 6 to 8 weeks in some studies but was unknown in other studies. Respiratory muscle exercises have been provided for the treatment of patients before and after cardiac surgery for improving their respiratory muscle strength and preventing complications. Studies have shown favourable useful effects of respiratory muscle training before and after surgery to reestablish and improve inspiratory muscle strength, 10, 11 increase forced vital capacity (VC), 14 and reduce the incidence of pneumonia and hospitalisation. 15 Conversely, other studies have not found any effect. 16 After surgery, lung function improves progressively; however, a postoperative decrease of lung function from 6% to 13% has been reported as compared with that in the preoperative period. 17 Numerous factors that affect postoperative lung function have been reported, e.g. postoperative inflammatory reaction, pleural variations, and atelectasis. 18 The reduction of lung function postoperatively has been emphasised with incisional pain; nevertheless, this resolves months after surgery. 17 The relationship between respiratory muscle strength and lung function after cardiac surgery is not known.
The purpose of this study was to evaluate the respiratory muscle strength before and 8 weeks after cardiac surgery and determine its relationship with lung function.
We hypothesised that the respiratory muscle strength will substantially decrease 8 weeks after cardiac surgery and is related to lung function.
Materials and Methods
This study was a prospective observational study and reviewed data from 42 patients who were included in a randomised control trial designed to investigate the effect of breathing exercises in post-cardiac surgery patients. 19 Ethical committee approval was obtained. The study protocol and procedures were explained to all subjects. Complete written informed consent was also obtained from all subjects before collecting their baseline measurement data. The study was conducted at the Delhi Heart and Lung Institute from 2014 to 2015.
Inclusion criteria
The inclusion criteria were as follows: age of >35 years, ability to communicate in local language or English language, upcoming valve surgery or coronary artery bypass surgery (cardiac surgery) via median sternotomy, ejection fraction of >35%, and presence of an internal mammary artery graft, a saphenous vein graft, or a radial graft.
Exclusion criteria
The exclusion criteria were as follows: emergency cardiac surgery, history of pulmonary or cardiac surgery, kidney disease, absence of the need for mechanical ventilation for >24 h or reintubation, and absence of infection or unstable sternum.
Procedures and settings
Physiotherapists recruited patients from the department of cardiothoracic and vascular surgery at the Delhi Heart and Lung Institute and obtained their preoperative data. Respiratory muscle strength, oxygen saturation, and spirometry results were assessed by pulmonary laboratory technologists from the department of pulmonology critical care and sleep medicine before and 8 weeks after surgery. The patients' medical records on physical condition were collected. The patients underwent surgery under general anaesthesia, and ventilation was preserved above 90% with supplemental oxygen. For the first four postoperative days, deep breathing exercises were performed hourly by all subjects. A positive end expiratory pressure device and an incentive spirometer were used for the breathing exercises. The exercise regime comprised three sets of 10 repetitions of deep breathing exercises, with a breath hold of 5e10 s and breathing out in the device. 19 During the first postoperative day, the breathing exercises were performed hourly. Progressive mobilisation was provided by the nursing staff and physiotherapists on the second postoperative day by making the patients sit on the side of their bed, followed by standing and short walking inside the room. On the third postoperative day, the patients were instructed to walk a longer distance in the passageway of the hospital. On the fourth postoperative day, the exercises were repeated. 19 Throughout hospitalisation, pain relievers (analgesics) were administered in all patients as per the regular routine in the hospital.
Outcomes and measurements
The respiratory muscle strength was assessed using the MEP and MIP produced in the mouth. During assessment, the patients were sitting and had to breathe through a mouth piece, while their nose was closed with a nasal clip. The MEP was measured near the total lung capacity after maximum inhalation and the MIP near the residual volume after maximum exhalation. The best values out of the three standard manoeuvres were noted. As per the American Thoracic Society/European Respiratory Society (ATS/ERS) 'Statement on Respiratory Muscle Testing', the inspiratory and expiratory muscle tests were standardised. The respiratory muscle strength was measured using the MIP and MEP generated at the mouth. The patients were in a seated position, breathing in a flanged mouthpiece and wearing a nose clip. The MIP was measured near the residual volume after maximal exhalation and the MEP near the total lung capacity after maximal inhalation. The highest values from three technically acceptable manoeuvres were recorded. The inspiratory and expiratory muscle tests were standardised, as described in the ATS/ERS 'Statement on Respiratory Muscle Testing'. 20 Further, the Jaeger respiratory drive MS-PFT/ muscle strength (Care Fusion Germany) was used. For assessing the MEP and MIP, non-invasive measurements were extensively applied and acknowledged. 11, 21, 22 The testretest reliability for patients with chronic obstructive pulmonary disease showed an r value of 0.97, 24 while that for healthy individuals showed an ICC of > 0.8. 23 For cardiac surgery patients, no reliability or validity tests have yet been established. According to Evans and Whitelaw, the MEP and MIP were related to age and sex for predicted values. 25 The inspiratory capacity (IC), VC, and forced expiratory volume in 1 s (FEV 1 ) were evaluated using the Jaeger Screen PFT/body box (Care Fusion Germany). In the sitting position, spirometry was performed and standardised as described in the ATS/ERS 'Standardisation of Spirometry'. 26, 27 The expected values for the IC, VC, and FEV 1 were correlated to sex, age, and height, as reported by Hedenstrom et al. 28, 29 Pulse oximetry was used for the measurement of oxygen saturation (Beurer GmbH, Germany), with a finger probe attached to the patients' finger.
Statistical analysis
Data were gathered from different healing centres in the western region of the KSA and made accessible by sex, age, indications, types, surgical type, hazard factors, nationality, and pre-and postoperative treatment type. The technique for information accumulation has been utilised for this examination reason for existing was affirmed by the medicinal moral panel and authority letter from the individual division. Data were gathered dependent of the manifestations and treatment provided with their age, sex, nationality, and healing centre subtleties.
Data were analyzed using the SPSS statistical software version 20, and the outcomes are shown in Table 2 and in Graph 1. Normality distribution was assessed using the KolmogoroveSmirnov test. The Pearson correlation of various variables, such as the preoperative and postoperative values of the MEP, MIP, oxygen saturation , and lung function, was assessed using Student's paired t-test and chi-square test. The results were presented as means AE standard deviations (SDs), with p value estimation (<0.05).
Results
A total of 42 patients undergoing CABG (n ¼ 28) and valve surgery (n ¼ 14) via average sternotomy with a mean age of 65 AE 7 years were surveyed (Table 1 ). There were no significant differences in the patient characteristics between the CABG patients and valve surgery patients.
The patient characteristics, e.g. age, body mass index (BMI), weight, and surgical status, are shown in Table 1 . There was a significant decrease in weight and BMI 2 months after cardiac surgery. These findings were anticipated. Eight patients were current smokers, and 12 and 13 had airflow obstruction and diabetes before surgery, respectively.
Regarding lung volumes, the VC, FVC, and FEV 1 significantly increased. The ERV increased, and the IRV decreased, keeping the VT unaltered 1 year after surgery. Further, respiratory perseverance evaluated using the MVV also increased after weight reduction (Table 2 ).
In the evaluation of the respiratory muscle quality, a decrease critical in the estimations of the MIP and MEP was recorded (Table 3) . The spirometric estimations were consistent with the anticipated values (VC, 92.29%; FEV 1 , 88.15%; IC, 92.05%); however, at the 2-month follow-up, the VC, FEV 1 , and IC decreased significantly at 3.4%, 6.83%, and 9.96%, respectively, compared with the preoperative values ( Table 2 ). The oxygen saturation was 97 AE 1% preoperatively and 98 AE 1% at the 2-month follow-up (p ¼ 0.07).
At the 2-month follow-up, the MIP was positively correlated with the VC (r ¼ 0.41, p ¼ 0.004), IC (r ¼ 0.22, p ¼ 0.0026), and FEV 1 (r ¼ 0.59, p ¼ 0.0078). Conversely, the MEP was not correlated with the VC, FEV 1 , and IC.
Discussion
Based on the obtained results, there was no significant change in the respiratory muscle strength 2 months after cardiac surgery as compared with that before surgery. In this study, we described the effect of cardiac surgery on respiratory muscle strength after discharge. In previous studies, there was an 11% and a 36% decrease in the MIP 5 and 6 days after surgery, respectively. 12, 13 This decrease in respiratory muscle strength may be attributed to the incisional pain in the sternum, which may hinder the performance of various tests. Whether surgeries themselves affect respiratory muscle strength or whether it is altered by the patients' inspiration in the presence of pain and abilities to perform tests postoperatively remains unclear. Thoracic wall distortion owing to median sternotomy reduces the patients' ability to breath and thoracic wall compliance. Changes in respiratory patterns, alterations in thoracic wall configuration, and decreases in thoracic wall compliance might be the mechanisms underlying the reduction of lung function measured 2 months after surgery. 30, 31 Two months after cardiac surgery, the measured lung function variables (IC, VC, and FEV 1 ) were correlated with the MIP. The relationship established in the acute phase between the FVC and MIP 30 remained 2 months after surgery. It has been reported that there is an association between the FVC and MIP in healthy individuals, 31 which supports the premise that lung function and respiratory 8, 11, 12 The outcomes may be dependent on the equipment for measurement, methods of tests, and expected values used for respiratory muscle strength.
In the ATS/ERS 'Statement on Respiratory Muscle Testing', 20 an MIP of >80 cmH 2 O is not considered to indicate a clinically significant respiratory muscle weakness. Nambiar and Ravindra 25 reported that an MIP of >50 cmH 2 O is sufficient for normal breathing and that an MEP of >60 cmH 2 O is necessary for generating an efficient cough. Furthermore, an MIP below 60 cmH 2 O may still be normal given that it is above the level required to sustain a normal VC. 25 Consequently, there is stagnant ambiguity regarding which degree of respiratory muscle strength is adequate for addressing postoperative lung impairment.
The effect of preoperative reduction of respiratory muscle strength in subjects after cardiac surgery has not been completely studied. Rodrigues et al. 8 established a relationship of impaired preoperative MEP and MIP (<70% of the expected value defined by Neder et al. 32 ) with the requirement for extended invasive mechanical ventilation.
In cardiac surgery patients, an MIP or MEP above 75% of the predictive value has been revealed to be protective against the development of postoperative pulmonary complications, e.g. fever (temperature of >37.5 C), atelectasis, pneumonia, and bronchitis throughout hospitalisation. 33e35 Contrarily, Riedi et al. 13 found no relationship between a weak preoperative respiratory muscle and postoperative pulmonary impairments. Thus, additional studies are required to determine the possible role of respiratory muscle strength in the progression of pulmonary impairments.
The SD for the MIP (74.56 AE 18.86 cmH 2 O) and MEP (88.86 AE 18.14 cmH 2 O) showed an extensive difference in respiratory muscle strength, and this difference is in agreement with earlier reports in cardiac surgery patients 10, 11, 16 and healthy subjects. 20 The limitation of this study was that the number of patients included was small (n ¼ 42) and that extremely ill subjects were not included; hence, the results cannot be generalised to all cardiac surgery patients.
Further, only a few female patients were included in this study. Patients with unstable angina before surgery were excluded in accordance with the ATS/ERS statement. 27 There was no noteworthy impairment in respiratory muscle strength in this study 2 months after cardiac surgery.
The respiratory muscle strength was not impaired, which may be an essential effect in some subjects; subsequently, the relationship between lung function and inspiratory muscle strength was established. Additional studies are required to determine subjects at a risk for reduced lung function, which may cause pulmonary complications or affect physical activity capacity 2 months after cardiac surgery.
Conclusion
The respiratory muscle strength measured on the basis of the MIP and MEP was consistent with the proposed values and between the preoperative period and 2-month follow-up. The VC, IC, and FEV 1 significantly decreased 2 months after cardiac surgery. Further, there was a relationship found between reduced inspiratory muscle strength and lung function. However, the mechanism underlying the reduction of lung function after 2 months remains unknown.
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